Efficacy of lignocaine nebulization in patients with COVID-19 respiratory infection: An exploratory randomized double-blinded controlled trial

Background and Aims: Coronavirus disease (COVID-19)-related pneumonia is proposed to be an inflammatory process. The treatment currently includes supportive therapy and low-dose steroids. Anti-inflammatory drugs have been proposed to prevent cytokine storms and improve oxygenation in such cases. The...

Full description

Bibliographic Details

Published in:	Journal of Anaesthesiology Clinical Pharmacology
Main Authors:	Praveen Talawar, Debendra Kumar Tripathy, Ashutosh Kaushal, Mridul Dhar, Adabala Vijaybabu, Praik Tuppad, Sangadala Priyanka, Deepak Kumar, Ruhi Sharma, Sumedha Suresh Kumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-04-01
Subjects:	covid-19 nebulized lignocaine pneumonia
Online Access:	https://journals.lww.com/10.4103/joacp.joacp_205_22